Framework for modeling a clinical trial study using a cross-over treatment design
AssigneeOracle International Corporation
InventorsScott Andrew Bockelman, John Caron, Naresh Baliga, Leyla Badakhshanian
Life of this patent
Estimating the term…
Loading patent…
AssigneeOracle International Corporation
InventorsScott Andrew Bockelman, John Caron, Naresh Baliga, Leyla Badakhshanian
Estimating the term…
The present disclosure provides for modeling a clinical trial study, which may implement a cross-over design. A plurality of treatments is generated for a clinical trial study, based on a first subset of operational parameters. A plurality of sequences is also generated for the clinical trial study, based on a second subset of the operational parameters. Each sequence of the plurality of sequences comprises a combination of ones of the plurality of treatments. A plurality of subject groups is assigned to the plurality of sequences, where one subject group of the plurality of subject groups is respectively assigned to one sequence of the plurality of sequences. The one sequence is administered to subjects of the one subject group during the clinical trial study.
A method, performed by a computer that includes at least a processor and a memory, the method comprising:
A non-transitory computer readable storage medium configured to store program instructions that, when executed on a processor, are configured to cause the processor to:
An apparatus comprising:
Dependencies are inferred from the claim text.